Sort by
Refine Your Search
-
methods for these diseases. Approaches range from human genetics, genomics, protein biochemistry and neuronal and glial cell biology to integrative systems and computational biology. Models include yeast
-
. Clinical studies have demonstrated that hereditary neuropathies can also involve muscle pathologies, complicate diagnosis and hamper therapy development. We have developed advanced in vitro cell models
-
of computational linguistics and crosslingual emotion detection Position You will work actively on the preparation of a PhD thesis in the context of the research project ‘Emotions without borders: Studying
-
. Clinical studies have demonstrated that hereditary neuropathies can also involve muscle pathologies, complicate diagnosis and hamper therapy development. We have developed advanced in vitro cell models
-
team of Prof. Seppe De Schepper investigates how peripheral immune signals influence brain health and disease. We focus on tissue-resident macrophages and immune cell trafficking from periphery to brain
-
life. The successful candidate will work closely with experts in food allergy, neuroimmunology, gut physiology, and computational biology to characterize immune cell responses, construct spatial maps
-
cell death resistance in CRC. Subsequently, you will study the impact of cancer therapeutics on CRC-associated mucin mRNA isoform expression and subsequent cell death signalling to unveil the potential
-
the imec-Vision Lab (image reconstruction, processing, and analysis), the Bio-Imaging Lab (preclinical neuro-MRI), and the Laboratory of Cell Biology and Histology (cell biology and advanced microscopy
-
towards cancer and has been linked to initiation, progression, and poor prognosis of colorectal cancer. Adenocarcinomas also overexpress transmembrane mucins to exploit their role in promoting tumour cell
-
the preparation and defence of a PhD thesis in the field of Medical Sciences. More specific, you will work on the validation of predictive peptide biomarkers to classify non-small cell lung cancer (NSCLC) patients